176 related articles for article (PubMed ID: 34785925)
41. STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits.
Chung SS; Giehl N; Wu Y; Vadgama JV
Int J Oncol; 2014 Feb; 44(2):403-11. PubMed ID: 24297508
[TBL] [Abstract][Full Text] [Related]
42. Exosome carrying PSGR promotes stemness and epithelial-mesenchymal transition of low aggressive prostate cancer cells.
Li Y; Li Q; Li D; Gu J; Qian D; Qin X; Chen Y
Life Sci; 2021 Jan; 264():118638. PubMed ID: 33164833
[TBL] [Abstract][Full Text] [Related]
43. Mesenchymal stem cells recruited by castration-induced inflammation activation accelerate prostate cancer hormone resistance via chemokine ligand 5 secretion.
Yu Y; Zhang Q; Ma C; Yang X; Lin R; Zhang H; Liu Y; Han Z; Cheng J
Stem Cell Res Ther; 2018 Sep; 9(1):242. PubMed ID: 30257726
[TBL] [Abstract][Full Text] [Related]
44. BCL11A enhances stemness and promotes progression by activating Wnt/β-catenin signaling in breast cancer.
Zhu L; Pan R; Zhou D; Ye G; Tan W
Cancer Manag Res; 2019; 11():2997-3007. PubMed ID: 31114347
[No Abstract] [Full Text] [Related]
45. The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways.
Shen C; Chen F; Wang H; Li G; Yu C; Wang X; Wen Z
Cell Physiol Biochem; 2018; 49(1):282-294. PubMed ID: 30138944
[TBL] [Abstract][Full Text] [Related]
46. Heteronemin Is a Novel c-Met/STAT3 Inhibitor Against Advanced Prostate Cancer Cells.
Wu JC; Wang CT; Hung HC; Wu WJ; Wu DC; Chang MC; Sung PJ; Chou YW; Wen ZH; Tai MH
Prostate; 2016 Dec; 76(16):1469-1483. PubMed ID: 27416770
[TBL] [Abstract][Full Text] [Related]
47. Interleukin-6 induces malignant transformation of rat mesenchymal stem cells in association with enhanced signaling of signal transducer and activator of transcription 3.
Cui X; Liu J; Bai L; Tian J; Zhu J
Cancer Sci; 2014 Jan; 105(1):64-71. PubMed ID: 24168060
[TBL] [Abstract][Full Text] [Related]
48. Ultrasound-Targeted Microbubble Destruction-Mediated Downregulation of EZH2 Inhibits Stemness and Epithelial-Mesenchymal Transition of Liver Cancer Stem Cells.
Wu J; Sun L; Liu T; Dong G
Onco Targets Ther; 2021; 14():221-237. PubMed ID: 33469303
[TBL] [Abstract][Full Text] [Related]
49. miR-297 Protects Human Umbilical Vein Endothelial Cells against LPS-Induced Inflammatory Response and Apoptosis.
Yao Y; Jia H; Wang G; Ma Y; Sun W; Li P
Cell Physiol Biochem; 2019; 52(4):696-707. PubMed ID: 30921508
[TBL] [Abstract][Full Text] [Related]
50. Poly r(C) binding protein-1 is central to maintenance of cancer stem cells in prostate cancer cells.
Chen Q; Cai ZK; Chen YB; Gu M; Zheng DC; Zhou J; Wang Z
Cell Physiol Biochem; 2015; 35(3):1052-61. PubMed ID: 25661993
[TBL] [Abstract][Full Text] [Related]
51. Impact of miR-223-3p and miR-2909 on inflammatory factors IL-6, IL-1ß, and TNF-α, and the TLR4/TLR2/NF-κB/STAT3 signaling pathway induced by lipopolysaccharide in human adipose stem cells.
Wu J; Niu P; Zhao Y; Cheng Y; Chen W; Lin L; Lu J; Cheng X; Xu Z
PLoS One; 2019; 14(2):e0212063. PubMed ID: 30807577
[TBL] [Abstract][Full Text] [Related]
52. 13
Wang L; Choi HS; Lee B; Choi JH; Jang YS; Seo JW
Antioxidants (Basel); 2021 Mar; 10(3):. PubMed ID: 33804152
[TBL] [Abstract][Full Text] [Related]
53. Neuroprotection by the histone deacetylase inhibitor trichostatin A in a model of lipopolysaccharide-sensitised neonatal hypoxic-ischaemic brain injury.
Fleiss B; Nilsson MK; Blomgren K; Mallard C
J Neuroinflammation; 2012 Apr; 9():70. PubMed ID: 22512781
[TBL] [Abstract][Full Text] [Related]
54. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
Xiao W; Gao Z; Duan Y; Yuan W; Ke Y
J Exp Clin Cancer Res; 2017 Mar; 36(1):41. PubMed ID: 28279221
[TBL] [Abstract][Full Text] [Related]
55. Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway .
Lou W; Ni Z; Dyer K; Tweardy DJ; Gao AC
Prostate; 2000 Feb; 42(3):239-42. PubMed ID: 10639195
[TBL] [Abstract][Full Text] [Related]
56. c-MYC functions as a molecular switch to alter the response of human mammary epithelial cells to oncostatin M.
Kan CE; Cipriano R; Jackson MW
Cancer Res; 2011 Nov; 71(22):6930-9. PubMed ID: 21975934
[TBL] [Abstract][Full Text] [Related]
57. Trichostatin a inhibits phenotypic transition and induces apoptosis of the TAF-treated normal colonic epithelial cells through regulation of TGF-β pathway.
Huang C; Wu XF; Wang XL
Int J Biochem Cell Biol; 2019 Sep; 114():105565. PubMed ID: 31278993
[TBL] [Abstract][Full Text] [Related]
58. Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.
Hellsten R; Johansson M; Dahlman A; Dizeyi N; Sterner O; Bjartell A
Prostate; 2008 Feb; 68(3):269-80. PubMed ID: 18163422
[TBL] [Abstract][Full Text] [Related]
59. Reciprocal activation between STAT3 and miR-181b regulates the proliferation of esophageal cancer stem-like cells via the CYLD pathway.
Xu DD; Zhou PJ; Wang Y; Zhang L; Fu WY; Ruan BB; Xu HP; Hu CZ; Tian L; Qin JH; Wang S; Wang X; Li YC; Liu QY; Ren Z; Zhang R; Wang YF
Mol Cancer; 2016 May; 15(1):40. PubMed ID: 27189061
[TBL] [Abstract][Full Text] [Related]
60. Lipopolysaccharide (LPS) enhances prostate cancer metastasis potentially through NF-κB activation and recurrent dexamethasone administration fails to suppress it in vivo.
Jain S; Dash P; Minz AP; Satpathi S; Samal AG; Behera PK; Satpathi PS; Senapati S
Prostate; 2019 Feb; 79(2):168-182. PubMed ID: 30264470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
